DLH Holdings Corp. (DLHC)
| Previous Close | 10.79 |
| Open | 10.75 |
| Bid | 10.68 x 200 |
| Ask | 10.95 x 100 |
| Day's Range | 10.69 - 10.96 |
| 52 Week Range | 9.01 - 17.58 |
| Volume | |
| Avg. Volume | 40,651 |
| Market Cap | 153.763M |
| Beta (5Y Monthly) | 1.22 |
| PE Ratio (TTM) | 77.18 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
DLH to Announce Fiscal 2024 Second Quarter Financial Results
ATLANTA, April 22, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release financial results for the fiscal second quarter ended March 31, 2024 on May 1, 2024 after the market closes. DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time the following day, May 2, 2024, during which members of senior management will make a brief presentation
- GlobeNewswire
DLH to Provide Information Technology Services to the National Cancer Institute
ATLANTA, March 07, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading Health IT provider of digital transformation and cybersecurity, science research and development, and systems engineering and integration, today announced that it has been awarded a contract to continue and expand its user-experience, technology refresh and IT services for the National Institutes of Health’s (“NIH”) National Cancer Institute (“NCI”). NCI, the largest institute under
- GlobeNewswire
DLH to Provide Information Technology Services at National Institute on Drug Abuse
ATLANTA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading Health IT provider of digital transformation and cybersecurity, science research and development, and systems engineering and integration, today announced that it has been awarded a contract to continue providing information technology services for the National Institutes of Health’s (“NIH”) National Institute on Drug Abuse (“NIDA”). NIDA is the lead federal agency supporting scientif
